Transgenomic Inc Share Price Nasdaq
Equities
US89365K3059
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
01/04 | Transcript : Precipio, Inc. - Special Call | |
29/03 | Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 9.41M 785M | Sales 2023 | 15.2M 1.27B | Capitalization | 9.23M 769M |
---|---|---|---|---|---|
Net income 2022 | -12M -1B | Net income 2023 | -5M -417M | EV / Sales 2022 | 1.12 x |
Net cash position 2022 | 2.05M 171M | Net cash position 2023 | 386K 32.18M | EV / Sales 2023 | 0.58 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.44
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 95.69% |
Latest transcript on Transgenomic Inc
Managers | Title | Age | Since |
---|---|---|---|
Ilan Danieli
CEO | Chief Executive Officer | 52 | 28/17/28 |
Matthew Gage
DFI | Director of Finance/CFO | 57 | 01/17/01 |
Ayman Mohamed
CTO | Chief Tech/Sci/R&D Officer | 39 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Andrews
BRD | Director/Board Member | 64 | 01/21/01 |
Kathy LaPorte
BRD | Director/Board Member | 62 | 09/18/09 |
Richard Sandberg
CHM | Chairman | 80 | 03/19/03 |
1st Jan change | Capi. | |
---|---|---|
-14.68% | 18.88B | |
-42.33% | 2.84B | |
+17.00% | 1.85B | |
-0.51% | 1.66B | |
+27.15% | 1.26B | |
-13.90% | 989M | |
-21.76% | 896M | |
-2.72% | 757M | |
-23.95% | 637M |